Literature DB >> 20590908

Preoperative body composition is influenced by the stage of operable pancreatic adenocarcinoma but does not predict survival after Whipple's procedure.

Alireza Aslani1, Anthony J Gill, Paul J Roach, Barry J Allen, Ross C Smith.   

Abstract

OBJECTIVES: Cachexia is common in pancreatic cancer and may have an influence on longterm survival but few studies have investigated this in patients with operable tumours. Therefore, this study was carried out to document body composition status in patients with pancreatic adenocarcinoma (PCa) presenting for a Whipple's procedure (WP) and to relate the findings to histopathology and longterm survival.
METHODS: Body composition was measured 1 day before a WP for ductal PCa in 36 patients (15 men, 21 women) aged 41-81 years. Results for total body nitrogen (TBN), nitrogen index (NI), total body water (TBW), fat mass (FM) and total body potassium (TBK) were compared with results in 73 age- and sex-matched controls. Patients' survival and details from histopathology synoptic reports were documented.
RESULTS: Patients undergoing WPs had low TBK values (P < 0.001) and females had lower body fat (P = 0.007) compared with controls. Five of 36 presented with significant protein deficiency, but this was not associated with a prolonged length of stay or reduced survival. The 12 patients who had involved surgical margins had larger tumours and reduced weight (P = 0.015), FM (P = 0.001), TBN (P = 0.045), TBK (P = 0.014) and survival (P = 0.036). However, multivariate Cox's regression analysis only included FM along with vascular invasion and margin status as independent predictors of survival.
CONCLUSIONS: PCa patients undergoing a WP have reduced body fat and TBK compared with community controls while those with stage III tumours had greater deficits of fat, TBK and protein stores. However, preoperative body composition was a poor predictor of postoperative survival after pathological data were considered.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20590908      PMCID: PMC2951821          DOI: 10.1111/j.1477-2574.2010.00171.x

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  43 in total

1.  Compartmental body composition based on total-body nitrogen, potassium, and calcium.

Authors:  S H Cohn; D Vartsky; S Yasumura; A Sawitsky; I Zanzi; A Vaswani; K J Ellis
Journal:  Am J Physiol       Date:  1980-12

2.  Factors influencing survival after resection for ductal adenocarcinoma of the head of the pancreas.

Authors:  G Benassai; M Mastrorilli; G Quarto; A Cappiello; U Giani; P Forestieri; F Mazzeo
Journal:  J Surg Oncol       Date:  2000-04       Impact factor: 3.454

3.  The predictive value of body protein for chemotherapy-induced toxicity.

Authors:  A Aslani; R C Smith; B J Allen; N Pavlakis; J A Levi
Journal:  Cancer       Date:  2000-02-15       Impact factor: 6.860

Review 4.  Nutritional effects of oesophageal, gastric and pancreatic carcinoma.

Authors:  R Gupta; H Ihmaidat
Journal:  Eur J Surg Oncol       Date:  2003-10       Impact factor: 4.424

5.  Estimation of total body water by bioelectrical impedance analysis.

Authors:  R F Kushner; D A Schoeller
Journal:  Am J Clin Nutr       Date:  1986-09       Impact factor: 7.045

6.  Prognostic factors following curative resection for pancreatic adenocarcinoma: a population-based, linked database analysis of 396 patients.

Authors:  Jonathan E Lim; Michael W Chien; Craig C Earle
Journal:  Ann Surg       Date:  2003-01       Impact factor: 12.969

7.  Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 481 men and women aged from 16 to 72 years.

Authors:  J V Durnin; J Womersley
Journal:  Br J Nutr       Date:  1974-07       Impact factor: 3.718

8.  Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma.

Authors:  M Wagner; C Redaelli; M Lietz; C A Seiler; H Friess; M W Büchler
Journal:  Br J Surg       Date:  2004-05       Impact factor: 6.939

9.  A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer.

Authors:  John P Neoptolemos; Deborah D Stocken; Helmut Friess; Claudio Bassi; Janet A Dunn; Helen Hickey; Hans Beger; Laureano Fernandez-Cruz; Christos Dervenis; François Lacaine; Massimo Falconi; Paolo Pederzoli; Akos Pap; David Spooner; David J Kerr; Markus W Büchler
Journal:  N Engl J Med       Date:  2004-03-18       Impact factor: 91.245

10.  Surgeon volume and operative mortality in the United States.

Authors:  John D Birkmeyer; Therese A Stukel; Andrea E Siewers; Philip P Goodney; David E Wennberg; F Lee Lucas
Journal:  N Engl J Med       Date:  2003-11-27       Impact factor: 91.245

View more
  7 in total

1.  Cachexia in pancreatic cancer: new treatment options and measures of success.

Authors:  Kenneth C H Fearon; Vickie E Baracos
Journal:  HPB (Oxford)       Date:  2010-06       Impact factor: 3.647

Review 2.  The impact of sarcopenia on survival and complications in surgical oncology: A review of the current literature.

Authors:  Savita Joglekar; Peter N Nau; James J Mezhir
Journal:  J Surg Oncol       Date:  2015-08-27       Impact factor: 3.454

3.  Serum apolipoprotein C-II is prognostic for survival after pancreatic resection for adenocarcinoma.

Authors:  A Xue; J W Chang; L Chung; J Samra; T Hugh; A Gill; G Butturini; R C Baxter; R C Smith
Journal:  Br J Cancer       Date:  2012-11-20       Impact factor: 7.640

Review 4.  An Australasian perspective on the curative treatment of patients with pancreatic cancer, supportive care, and future directions for management.

Authors:  Wendy Muircroft
Journal:  Ecancermedicalscience       Date:  2016-12-07

5.  Elevated Serum Interleukin-8 Level Correlates with Cancer-Related Cachexia and Sarcopenia: An Indicator for Pancreatic Cancer Outcomes.

Authors:  Ya-Chin Hou; Chih-Jung Wang; Ying-Jui Chao; Hao-Yun Chen; Hao-Chen Wang; Hui-Ling Tung; Jung-Ting Lin; Yan-Shen Shan
Journal:  J Clin Med       Date:  2018-12-01       Impact factor: 4.241

6.  The Relationship between Nutritional Status and Body Composition with Clinical Parameters, Tumor Stage, CA19-9, CEA Levels in Patients with Pancreatic and Periampullary Tumors.

Authors:  Aneta Jachnis; Maciej Tomasz Słodkowski
Journal:  Curr Oncol       Date:  2021-11-17       Impact factor: 3.677

7.  Sarcopenia and sarcopenic obesity are independent adverse prognostic factors in resectable pancreatic ductal adenocarcinoma.

Authors:  Elisabeth S Gruber; Gerd Jomrich; Dietmar Tamandl; Michael Gnant; Martin Schindl; Klaus Sahora
Journal:  PLoS One       Date:  2019-05-06       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.